İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025 · article

Efficacy of hypertonic nasal spray with algae in rhinosinusitis

YÖKSİS OpenAlex Açık erişim · hybrid
Yıl2025
Atıf1OpenAlex
Yüzdelik%65,7
FWCI0,721,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıEuropean Archives of Oto-Rhino-Laryngology
  • Katalog eşleşmesi (ISSN)European Archives of Oto-Rhino-Laryngology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

OBJECTIVES: We aimed to evaluate the effectiveness of nasal irrigation sprays at treating rhinosinusitis by easing congestion in the nose and other symptoms. METHODS: Plus Algae ENT hypertonic nasal spray (n = 600), and a third used an isotonic saline nasal spray (n = 500). Before and after therapy, patients had their symptoms and turbinates examined, overall symptoms scored, and quality of life (QoL) evaluated. RESULTS: The findings showed that both groups saw a decrease in symptom scores for anterior discharge, postnasal drip, headache, and obstruction with therapy, as well as an improvement in turbinate color and edema (p < 0.05). Quality of life (QoL) ratings rose, and total symptom scores fell during therapy. The group that used hypertonic nasal spray with algae had considerably fewer overall symptom scores than the other groups (hypertonic nasal spray and saline). The hypertonic nasal spray group reported substantially fewer symptoms than the saline group. For what concerns quality of life, the saline group had significantly worse scores than groups 1 and 2; groups 1 and 2 were similar to one another. CONCLUSION: We found that compared to hypertonic and saline nasal sprays, the algae-containing hypertonic spray reduced total symptom scores more than the other sprays. This indicated that irrigation based on algae-containing hypertonic nasal sprays could be the treatment of choice for the management of symptoms in rhinosinusitis patients. CLINICAL TRIAL NUMBER: The study was registered to ClinicalTrials.gov Protocol Registration and Results System (PRS) with a Clinical trial number of E-95961207-202.3.02-2955.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

1atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yazarlar

16
  1. ZEYNEL ÖZTÜRK 1
  2. NURAY BAYAR MULUK 2
  3. rahime koca 3
  4. NECDET ÖZÇELİK 4
  5. ELVIN ALASKAROV 5
  6. İBRAHİM ÇUKUROVA 6
  7. ERDEM ATALAY ÇETİNKAYA 7
  8. ÖZGÜR YÖRÜK 8
  9. CENGİZ BAL 9
  10. ARZU TATAR 10
  11. NİHAT SUSAMAN 11
  12. NAGEHAN DİLŞAD ERDOĞMUŞ KÜÇÜKCAN 12
  13. AYTEN GÜNER ATAYOĞLU 13
  14. ENES GÜNGÖR 14
  15. BURAK MUSTAFA TAŞ KIRIKKALE ÜNİVERSİTESİ 15
  16. CEMAL CİNGİ 16